Linked Life Data

20824268

Source:http://linkedlifedata.com/resource/pubmed/id/20824268

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2010-11-5
pubmed:abstractText
Lifelong anticoagulation, mainly with oral Vitamin K antagonists, represents the treatment of choice in patients with prosthetic heart valves to prevent thrombembolic complications. As a result, anticoagulant-related complications like excessive bleeding during interventions or surgical procedures will occur. Therefore, timely stopping of vitamin K antagonists prior to elective surgery is mandatory. However, based on the long half-life of all common vitamin K antagonists, interruption of oral anticoagulation will definitively lead to an increase of thrombembolic events. Hence, adequate bridging anticoagulation by temporary substitution of this therapy with heparin is necessary. This article gives a recommendation on the basis of the American College of Chest Physician and European Society of Cardiology current.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1433-0563
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1368-71
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
[Perioperative antocoagulation in patients with prosthetic heart valves: recommendations].
pubmed:affiliation
Klinik für Thorax- und Kardiovaskuläre Chirurgie, Westdeutsches Herzzentrum, Universitätsklinikum Essen, Hufelandstraße 55, 45122 Essen, Deutschland. daniel.wendt@uk-essen.de
pubmed:publicationType
Journal Article, English Abstract, Review